18. Interest in associates
 
  2018 
R’000 
    2017 
R’000 
 
Listed associates  4 469 751        4 661 516    
   Net asset value at acquisition 1 430 447        1 425 513    
   Inherent goodwill  4 083 041        4 073 768    
   Remeasurement allowances  (1 043 737)       (837 765)   
Unlisted associates  54 841        104 182    
   Net asset value at acquisition  199 272        205 876    
   Inherent goodwill  6 584        6 732    
   Remeasurement allowances  (151 015)       (108 426)   
Investments in associates at cost net of remeasurement allowances  4 524 592        4 765 698    
Attributable share of post-acquisition reserves of associates  817 416        608 790    
   At beginning of year  608 790        442 176    
   Share of current year earnings net of dividend  217 004        264 737    
   Share of movement in other reserves  (19 172)       (69 191)   
   Reversal of prior year reserves on unbundling, disposal, and or change in shareholding  10 794        (28 932)   
Advances to associates  19        840    
   5 342 027        5 375 328    

Unsecured advances to associates are interest-free and have no fixed terms of repayment.

A list of the Group’s significant associates, their country of incorporation and principal place of business, the Group’s percentage shareholding and an indication of their nature of business is included on Annexure A to these financial statements.

The Group’s most significant associate is Adcock Ingram Holdings Limited (Adcock). Adcock is a leading South African pharmaceutical manufacturer, listed on the Johannesburg Stock Exchange. The company manufactures, markets and distributes a wide range of healthcare products to both the private and public sectors of the market.

The Group holds an effective 38,5% (2017: 38,4%) of the net ordinary shares in issue in Adcock, but equity accounts for 45,2% (2017: 45,0%) of its results as a consequence of treating the sale of 15% of its holding, in terms of the new Adcock BEE scheme to Ad-izinyosito, as a deferred sale.

Full details of Adcock’s results can be found at www.adcock.co.za.

  For the
year ended
30 June
2018
R’000
    For the
year ended
30 June
2017
R’000
 
Summarised aggregated financial information of Adcock:          
Revenue  6 562 865        5 957 700    
Profit for the year  637 943        553 534    
Other comprehensive income for the year  7 040        (147 966)   
Total comprehensive income for the year  644 983        405 568    
Dividends received from Adcock during the year  106 848        77 024    
Current assets  3 617 934        3 326 463    
Non-current assets  2 652 791        2 236 510    
Current liabilities  (2 220 552)       (1 726 546)   
Non-current liabilities  (135 254)       (341 423)   
Non-controlling interests  (2 413)       (7 522)   
Reconciliation of the above summarised financial information to the carrying amount of Adcock recognised in the consolidated financial statements:              
Net assets of Adcock  3 912 506        3 487 482    
Proportion of Group’s interest in Adcock  1 767 699        1 570 947    
Inherent goodwill  3 734 763        3 767 061    
Provision for impairment of carrying value  (842 742)       (773 352)   
Carrying value of Group’s interest in Adcock  4 659 720        4 564 656    
Market value as at 30 June  4 659 720        4 564 656    

The investment in Adcock forms part of the corporate and investment operating segment. The recoverable amount of the investment has been assessed with reference to the fair value determined based on the quoted market price at the year ended 30 June 2018. This measurement is considered to be “Level 1” in the fair value hierarchy. The Group assessed the carrying value and remeasured the investment to recoverable fair value.

The same impairment considerations have been applied to other listed investments in associates.

  2018 
R’000 
    2017 
R’000 
 
Summarised aggregated financial information of associates that are not individually material:          
The Group’s share of profit 141 223      129 728   
The Group’s share of other comprehensive loss (830)     (637)  
The Group’s share of total comprehensive income 140 393      129 091   
Aggregate carrying amount of the Group investment in these associates 682 308      810 672